Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

6 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

N/A

2(40.0%)

Phase 3

1(20.0%)

5Total

Phase 2(2)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06686979Recruiting

PDO Based Drug Sensitive Test in R/M SGC

Role: collaborator

NCT06686342Recruiting

PDO Based Drug Sensitive Test in R/M HNSCC

Role: collaborator

NCT07078890Not ApplicableRecruiting

Effect of Bone Augmentation Simultaneous to Implant Removal on the Prognosis of Reimplantation at the Same Site

Role: collaborator

NCT06277791Phase 2Recruiting

The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma

Role: lead

NCT06942130Not ApplicableCompleted

The Application of Artificial Intelligence in Dental Education

Role: lead

NCT04649476Phase 2Completed

Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma

Role: lead

NCT06579768Recruiting

Radiomics for Preoperative Jaw Cyst Differentiation

Role: collaborator

NCT05798793Phase 3Recruiting

Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma

Role: lead

NCT06208254Unknown

Prevalence and Risk Indicators of Peri-implant Diseases in China

Role: collaborator

All 9 trials loaded